Concepedia

Chang G. Peng

CG

11

Publications

2.4K

Citations

11

H-Index

2007

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Harvard University

McGill University

Massachusetts Institute of Technology

Massachusetts General Hospital

Chang G. Peng is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, natural sciences, and biochemistry.

Top concepts

Publications per year

2007–2015

11

Publications

11

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

Hyukjin Lee, Abigail K. R. Lytton‐Jean, Yi Chen et al. · Nature Nanotechnology · 2012 · 1.2K citations · Full text

Rab5 is necessary for the biogenesis of the endolysosomal system in vivo

Anja Zeigerer, Jérôme Gilleron, Roman L. Bogorad et al. · Nature · 2012 · 363 citations

, , +5

siRNA Conjugates Carrying Sequentially Assembled Trivalent <i>N-</i>Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing <i>In Vivo</i> in Hepatocytes

Shigeo Matsuda, Kristofer Keiser, Jayaprakash K. Nair et al. · ACS Chemical Biology · 2015 · 206 citations

A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development

Mariano Severgnini, Jennifer Sherman, Alfica Sehgal et al. · Cytotechnology · 2011 · 171 citations · Full text

, , +10

G-quadruplex induced stabilization by 2′-deoxy-2′-fluoro-d-arabinonucleic acids (2′F-ANA)

Chang G. Peng, Masad J. Damha · Nucleic Acids Research · 2007 · 132 citations · Full text

Rows per page

1–5 of 11